Report #2825411

Received Feb 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (1)

Back pain

Symptom narrative

back pain; This non-serious case was reported by a physician via sales rep and described the occurrence of back pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Additional patient notes included Age: more than 50 years. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced back pain (Verbatim: back pain). The outcome of the back pain was not reported. It was unknown if the reporter considered the back pain to be related to Shingrix. It was unknown if the company considered the back pain to be related to Shingrix. Additional Information: GSK Receipt Date: 03-FEB-2025 A patient received the second dose of Shingrix and experienced back pain which messed up his back.

Medical history

Comments: Age: more than 50 years